RSS-Feed abonnieren

DOI: 10.1055/a-2713-5817
An Affordable In-house Tubular Retractor for Evacuation of Intracerebral Hematomas: A Case Series and Literature Review
Authors
Funding Information This work was supported by the National Science, Research, and Innovation Fund (NSRF) and the Prince of Songkla University (grant number MED6505161S) for developing and making the in-house tubular retractor. Funding from the Faculty of Medicine, Prince of Songkla University supported the English editing. The funders had no role to play in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the article for publication.

Abstract
Background
Intracerebral hemorrhage (ICH) disproportionately affects low- and middle-income countries (LMICs), where prevalence and outcomes are poor. Surgical intervention is often necessary in life-threatening cases. This study explored the feasibility of using a low-cost, in-house tubular retractor for ICH evacuation in a resource-limited setting.
Methods
We retrospectively reviewed adults with spontaneous supratentorial ICH who underwent evacuation with an International Organization for Standardization (ISO)-compliant, in-house tubular retractor (production cost approximately $60) between January 2023 and June 2024. Outcomes included hematoma volume reduction, correction of midline shift, perioperative complications, reoperation, hospital stay, and Glasgow Coma Scale (GCS) scores at discharge and 6 months.
Results
A total of 18 patients (13 males, 5 females; mean age 60.6 ± 13.8 years) underwent surgery. Median hematoma volume was 65.3 cm3 (IQR, 48.5–93.8), with a mean reduction of 81.2% ± 11.7 (median 83.9% [IQR 73.4–88.3]). Midline shift correction averaged 58.5% ± 28.0 (median 55.9% [IQR 43.7–69.6]). Hematoma evacuation was similar whether surgery occurred within 6 hours or later (79.8% vs. 83.5%, p = 0.49). Putaminal and frontal hematomas (n = 14) showed greater reduction than non-putaminal (n = 4), though not statistically significant. Median hospital stay was 23.5 days (IQR, 14.5–50.5). At 6 months, median GCS improved from 13 (IQR, 9–14) at discharge to 15 (IQR, 12–15). Two patients died of non-neurological causes.
Conclusion
Use of an in-house, ISO-compliant tubular retractor is feasible and cost-effective for intracerebral hematoma evacuation in resource-limited settings. These preliminary findings support further investigation to refine the technique and assess its clinical impact.
Contributors' Statement
A.K.: conceptualization, data curation, formal analysis, writing—original draft; W.K.K.: methodology, data curation, writing—original draft; S.C.: supervision, data curation; K.O.: supervision, data curation; W.S.: project administration, data curation; K.S.: data curation; C.T.: data curation. All authors reviewed and approved the final manuscript.
Publikationsverlauf
Eingereicht: 05. März 2025
Angenommen: 21. September 2025
Artikel online veröffentlicht:
15. Oktober 2025
© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution 4.0 International License, permitting copying and reproduction so long as the original work is given appropriate credit (https://creativecommons.org/licenses/by/4.0/)
Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
-
References
- 1 GBD 2019 Stroke Collaborators. Global, regional, and national burden of stroke and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurol 2021; 20 (10) 795-820
- 2 Greenberg SM, Ziai WC, Cordonnier C. et al; American Heart Association/American Stroke Association. 2022 guideline for the management of patients with spontaneous intracerebral hemorrhage: a guideline from the American Heart Association/American Stroke Association. Stroke 2022; 53 (07) e282-e361
- 3 Cabral NL, Nagel V, Conforto AB. et al. Five-year survival, disability, and recurrence after first-ever stroke in a middle-income country: a population-based study in Joinvile, Brazil. Int J Stroke 2018; 13 (07) 725-733
- 4 Langhorne P, O'Donnell MJ, Chin SL. et al; INTERSTROKE collaborators. Practice patterns and outcomes after stroke across countries at different economic levels (INTERSTROKE): an international observational study. Lancet 2018; 391 (10134): 2019-2027
- 5 Gerstl JVE, Blitz SE, Qu QR. et al. Global, regional, and national economic consequences of stroke. Stroke 2023; 54 (09) 2380-2389
- 6 Kelly PJ, Goerss SJ, Kall BA. The stereotaxic retractor in computer-assisted stereotaxic microsurgery. Technical note. J Neurosurg 1988; 69 (02) 301-306
- 7 Raza SM, Recinos PF, Avendano J, Adams H, Jallo GI, Quinones-Hinojosa A. Minimally invasive trans-portal resection of deep intracranial lesions. Minim Invasive Neurosurg 2011; 54 (01) 5-11
- 8 Echeverry N, Mansour S, MacKinnon G, Jaraki J, Shapiro S, Snelling B. Intracranial tubular retractor systems: a comparison and review of the literature of the BrainPath, Vycor, and METRx tubular retractors in the management of deep brain lesions. World Neurosurg 2020; 143: 134-146
- 9 Hersh EH, Gologorsky Y, Chartrain AG, Mocco J, Kellner CP. Minimally invasive surgery for intracerebral hemorrhage. Curr Neurol Neurosci Rep 2018; 18 (06) 34
- 10 Fu C, Wang N, Chen B. et al. surgical management of moderate basal ganglia intracerebral hemorrhage: comparison of safety and efficacy of endoscopic surgery, minimally invasive puncture and drainage, and craniotomy. World Neurosurg 2019; 122: e995-e1001
- 11 Zheng Z, Wang Q, Sun S, Luo J. Minimally invasive surgery for intracerebral and intraventricular hemorrhage. Front Neurol 2022; 13: 755501
- 12 Assina R, Rubino S, Sarris CE, Gandhi CD, Prestigiacomo CJ. The history of brain retractors throughout the development of neurological surgery. Neurosurg Focus 2014; 36 (04) E8
- 13 Sharif S, Shaikh MY, Ali SM. Novel tool for minimally invasive brain surgery—syringe port system. World Neurosurg 2019; 131: 339-345
- 14 Hannah TC, Kellner R, Kellner CP. Minimally invasive intracerebral hemorrhage evacuation techniques: a review. Diagnostics (Basel) 2021; 11 (03) 576
- 15 Larson AS, Zuccarello M, Grande AW. Minimally-invasive tubular retraction ports for intracranial neurosurgery: history and future perspectives. J Clin Neurosci 2021; 89: 97-102
- 16 Gregson BA, Mitchell P, Mendelow AD. Surgical decision making in brain hemorrhage. Stroke 2019; 50 (05) 1108-1115
- 17 Guo G, Pan C, Guo W. et al. Efficacy and safety of four interventions for spontaneous supratentorial intracerebral hemorrhage: a network meta-analysis. J Neurointerv Surg 2020; 12 (06) 598-604
- 18 Sun S, Li Y, Zhang H. et al. Neuroendoscopic surgery versus craniotomy for supratentorial hypertensive intracerebral hemorrhage: a systematic review and meta-analysis. World Neurosurg 2020; 134: 477-488
- 19 Yudkoff CJ, Rossitto CP, Kellner CP. Minimally invasive intracerebral hemorrhage evacuation: a bibliometric analysis of current research trends. Clin Neurol Neurosurg 2023; 227: 107672
- 20 Mendelow AD, Gregson BA, Rowan EN, Murray GD, Gholkar A, Mitchell PM. STICH II Investigators. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial lobar intracerebral haematomas (STICH II): a randomised trial. Lancet 2013; 382 (9890): 397-408
- 21 Yu Z, Zheng J, Guo R. et al. Prognostic significance of ultraearly hematoma growth in spontaneous intracerebral hemorrhage patients receiving hematoma evacuation. World Neurosurg 2018; 109: e651-e654
- 22 Kellner CP, Song R, Ali M. et al. Time to evacuation and functional outcome after minimally invasive endoscopic intracerebral hemorrhage evacuation. Stroke 2021; 52 (09) e536-e539
- 23 Liu M, Wang Z, Meng X. et al. Predictive nomogram for unfavorable outcome of spontaneous intracerebral hemorrhage. World Neurosurg 2022; 164: e1111-e1122
- 24 Pradilla G, Ratcliff JJ, Hall AJ. et al; ENRICH Trial Investigators. Trial of early minimally invasive removal of intracerebral hemorrhage. N Engl J Med 2024; 390 (14) 1277-1289
- 25 Hemphill III JC, Bonovich DC, Besmertis L, Manley GT, Johnston SC. The ICH score: a simple, reliable grading scale for intracerebral hemorrhage. Stroke 2001; 32 (04) 891-897
- 26 Kashkoush AI, El-Abtah ME, Achey R. et al. Prognosticators of functional outcome after supratentorial minimally invasive intracranial hemorrhage evacuation with tubular retractor systems. Oper Neurosurg (Hagerstown) 2023; 25 (05) 408-416
- 27 Roca E, Ramorino G. Brain retraction injury: systematic literature review. Neurosurg Rev 2023; 46 (01) 257
- 28 Griffiths E, Jayamohan J, Budday S. A comparison of brain retraction mechanisms using finite element analysis and the effects of regionally heterogeneous material properties. Biomech Model Mechanobiol 2024; 23 (03) 793-808
- 29 Zhenzhu L, Ruiyu X, Wei C. et al. Novel cost-effective tubular port based on glove and syringe for endoscopic surgery of intracerebral hematomas. World Neurosurg 2020; 135: 367-374.e1
- 30 Orlev A, Kimchi G, Oxman L. et al. Minimally invasive intracerebral hematoma evacuation using a novel cost-effective tubular retractor: Single-center experience. World Neurosurg 2021; 150: 42-53
- 31 Singh H, Patir R, Vaishya S, Miglani R, Kaur A. Syringe port: a convenient, safe, and cost-effective tubular retractor for transportal removal of deep-seated lesions of the brain. World Neurosurg 2018; 114: 117-120
- 32 Singh L, Agrawal N. Cylindrical channel retractor for intraventricular tumour surgery—a simple and inexpensive device. Acta Neurochir (Wien) 2009; 151 (11) 1493-1497
- 33 Almubarak AO, Alobaid A, Qoqandi O, Bafaquh M. Minimally invasive brain port approach for accessing deep-seated lesions using simple syringe. World Neurosurg 2018; 117: 54-61
- 34 Garcia-Estrada E, Morales-Gómez JA, Garza-Báez A. et al. 3D-printed endoport vs. open surgery for evacuation of deep intracerebral hemorrhage. Can J Neurol Sci 2022; 49 (05) 636-643
- 35 International Organization for Standardization. ISO 10993–1:2018. Biological evaluation of medical devices. Part 1: Evaluation and testing within a risk management process. 2024. Accessed June 18, 2024 at: https://www.iso.org/standard/68936.html
- 36 Kanďárová H, Pôbiš P. The “Big Three” in biocompatibility testing of medical devices: implementation of alternatives to animal experimentation-are we there yet?. Front Toxicol 2024; 5: 1337468
- 37 Hong CS, Prevedello DM, Elder JB. Comparison of endoscope- versus microscope-assisted resection of deep-seated intracranial lesions using a minimally invasive port retractor system. J Neurosurg 2016; 124 (03) 799-810
- 38 Abdala-Vargas NJ, Umana GE, Patiño-Gomez JG. et al. Standardization of strategies to perform a parafascicular tubular approach for the resection of brain tumors in eloquent areas. Brain Sci 2023; 13 (03) 498